Covington Capital Management Arvinas, Inc. Transaction History
Covington Capital Management
- $23.2 Billion
- Q3 2022
A detailed history of Covington Capital Management transactions in Arvinas, Inc. stock. As of the latest transaction made, Covington Capital Management holds 25 shares of ARVN stock, worth $437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$437
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$124 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$118 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$110 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$71.8 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$58.4 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $931M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...